US$ 24.22
glp-1 receptor agonists for type 2 diabetes GLP-1RAs Reduce External Eating Behavior with GLP-1 receptor agonists in the
Description
Additionally, unlike several other studies,811 our study population did not exclude patients with a history of self-harm or suicidal ideation, who could be those at the highest risk of experiencing adverse psychiatric events associated with GLP-1 receptor agonist use

Mol Metab 2019;30:72130.PubMedPMC 27

The effect is most noticeable during the active dose-escalation phase and the first few weeks at target dose

Denmark: Novo Nordisk A/S

RazaviNematollahi L

[DOI] [PubMed] [Google Scholar] [147].Seino Y, Min KW, Niemoeller E, Takami A, E.G.-L.A.S
